Molecular Biomedicine

SCIE

國(guó)際簡(jiǎn)稱：Molecular Biomedicine 參考譯名：分子生物醫(yī)學(xué)

主要研究方向：Biochemistry, Genetics and Molecular Biology-Molecular Medicine 非預(yù)警期刊審稿周期： 10 Weeks

《分子生物醫(yī)學(xué)》(Molecular Biomedicine)是一本由Springer出版的以Biochemistry, Genetics and Molecular Biology-Molecular Medicine為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

4區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
41 年發(fā)文量
6.3 IF影響因子
開(kāi)放 是否OA
English 出版語(yǔ)言

Molecular Biomedicine, launched in 2020, is a peer-reviewed, open access journal published annually. It is a collaborative venture between the globally renowned scientific publishing company Springer Nature and the Sichuan Association for the Promotion of International Medical Exchange. This journal is dedicated to publishing high-quality research in the field of biomedicine from a molecular perspective, encompassing both fundamental and clinical studies.

Focusing on the mechanisms of human disease, as well as advancements in prevention, diagnosis, and treatment, Molecular Biomedicine aims to become a leading international academic journal with a significant impact in the biomedicine sector. The journal's commitment to open access ensures that its content is widely accessible, fostering global exchange of scientific knowledge and accelerating the dissemination of breakthroughs in molecular medicine.By embracing innovative research methodologies and interdisciplinary approaches, Molecular Biomedicine is positioned to contribute to the advancement of medical science, offering insights that could potentially lead to improved healthcare outcomes. The journal's editorial board, composed of experts from around the world, ensures that the published work meets the highest standards of scientific rigor and integrity, solidifying its reputation as a trusted source of information in the scientific community.

[ 查看全部 ]

投稿咨詢加急咨詢

Molecular Biomedicine期刊信息

ISSN：2662-8651
出版語(yǔ)言：English
是否OA：開(kāi)放
E-ISSN：2662-8651
出版地區(qū)：Switzerland
是否預(yù)警：否
出版商：Springer
Gold OA文章占比：100.00%
研究類文章占比：60.98%

Molecular Biomedicine CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

6.3

1.455

0.902

學(xué)科類別	分區(qū)	排名	百分位
大類：Biochemistry, Genetics and Molecular Biology 小類：Molecular Medicine	Q2	80 / 178	55%
大類：Biochemistry, Genetics and Molecular Biology 小類：Molecular Biology	Q2	200 / 410	51%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Molecular Biomedicine中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學(xué) CELL BIOLOGY 細(xì)胞生物學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn)	4區(qū) 4區(qū) 4區(qū)

Molecular Biomedicine JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOCHEMISTRY & MOLECULAR BIOLOGY	ESCI	Q1	43 / 313	86.4%
學(xué)科：CELL BIOLOGY	ESCI	Q1	45 / 205	78.3%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	ESCI	Q1	27 / 189	86%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOCHEMISTRY & MOLECULAR BIOLOGY	ESCI	Q2	111 / 313	64.7%
學(xué)科：CELL BIOLOGY	ESCI	Q2	83 / 205	59.76%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	ESCI	Q2	71 / 189	62.7%